DENDREON CORP's ticker is DNDNQ and the CUSIP is 24823Q107. A total of 133 filers reported holding DENDREON CORP in Q4 2013. The put-call ratio across all filers is 2.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $191,000 | +27.3% | 132,746 | +103.2% | 0.00% | 0.0% |
Q2 2014 | $150,000 | -60.0% | 65,318 | -47.9% | 0.00% | -66.7% |
Q1 2014 | $375,000 | -2.3% | 125,314 | -2.5% | 0.00% | 0.0% |
Q4 2013 | $384,000 | +1.9% | 128,590 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $377,000 | -28.9% | 128,590 | -0.0% | 0.00% | -25.0% |
Q2 2013 | $530,000 | – | 128,611 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 1,824,183 | $2,627,000 | 0.05% |
ARISTEIA CAPITAL, L.L.C. | 1,000,000 | $1,440,000 | 0.05% |
Quotient Investors, LLC | 156,100 | $225,000 | 0.05% |
Spark Investment Management LLC | 208,900 | $300,000 | 0.04% |
WOLVERINE ASSET MANAGEMENT LLC | 26,236 | $2,019,000 | 0.04% |
TANG CAPITAL MANAGEMENT LLC | 55,548 | $80,000 | 0.04% |
Point72 Asset Management, L.P. | 3,000,000 | $4,320,000 | 0.03% |
Tower Research Capital LLC (TRC) | 154,756 | $223,000 | 0.02% |
Adamant Biomedical Investments AG | 50,000 | $72,000 | 0.02% |
A.R.T. Advisors, LLC | 261,266 | $376,000 | 0.02% |